[Guide lines for the treatment of patients with the apallic and postopallic syndrome].
D000596:Amino Acids / Q000627:therapeutic use; D001927:Brain Diseases / Q000188:drug therapy / Q000628:therapy; D001930:Brain Injuries / Q000150:complications / Q000378:metabolism; D002100:Cachexia / Q000517:prevention & control; D002540:Cerebral Cortex; D003286:Contracture / Q000517:prevention & control; D004035:Diet Therapy; D004044:Dietary Proteins / Q000008:administration & dosage; D004750:Enteral Nutrition; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D009584:Nitrogen / Q000378:metabolism; D003668:Pressure Ulcer / Q000517:prevention & control; D011433:Propranolol / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy / Q000209:etiology; D014140:Tracheotomy; D014474:Unconsciousness / Q000150:complications / Q000378:metabolism / Q000628:therapy; D014945:Wound Healing
D000596:Amino Acids; D004044:Dietary Proteins; D011433:Propranolol; D005947:Glucose; D009584:Nitrogen
Behandlungsrichtlinien für Patienten im apallischen und postapallischen Syndrom.